Healthcare startups usually fall into two camps. One builds software and apps; the other opens physical practices. Patient21, a German company that combines a digital front end with brick-and-mortar clinics, raised $108 million to expand beyond its home market. The funding is a bet that patients want both: the convenience of an app and the reassurance of a doctor down the street.
What a hybrid model looks like
A patient books an appointment through a mobile app, sees a nurse or doctor at a nearby clinic and receives follow-up messages, prescriptions and test results digitally. Behind the scenes, the company runs practices with shared systems for scheduling, records and billing. The digital layer reduces administrative work, and the physical clinic handles examinations, procedures and care that cannot be delivered remotely.
Why not just telemedicine?
- Limits of video. Many conditions need a physical exam, tests or procedures.
- Trust. Patients often prefer a clinic they can visit, especially for long-term issues.
- Regulation. Rules in many countries limit remote prescribing or require in-person checks.
- Coordination. Combining online and offline care lets one provider manage a patient’s journey from first contact to treatment.
How the economics work
Clinics are expensive to open and staff, so the business depends on seeing many patients efficiently. Software can help by filling schedules, reducing no-shows, automating paperwork and letting doctors spend more time with patients. Revenue typically comes from public insurance reimbursements, private insurance and self-pay services. The model needs scale to cover fixed costs, which is why funding rounds like this are often used to open more locations.
Challenges of expanding to new countries
- Different rules. Healthcare systems vary: how doctors are paid, which services are covered and who can own a practice.
- Licensing. Clinicians and clinics must meet local qualifications and standards.
- Data protection. Patient records are among the most sensitive data, and laws on storage and sharing differ.
- Recruiting. Doctor and nurse shortages make staffing a bottleneck in many regions.
- Culture. Patients in different countries have different expectations about appointments, waiting and communication.
What patients should look for
If a clinic of this type opens near you, ask practical questions. Which insurers does it accept? Who owns your medical records, and can you export them? How quickly can you get an appointment, and who do you reach after hours? Can you choose your doctor, and what happens if you want to switch? And, as with any health service, check the credentials of the practitioners.
Risks for the industry
Healthcare is full of cautionary tales about startups that grew too fast. Opening clinics ahead of demand burns cash, and quality can suffer when management stretches across many sites. Investors will watch for signs of sustainable unit economics, such as patients per clinician per day, patient retention and the cost of opening each new site. Regulators will watch for how data is handled and how care quality is measured.
What it suggests about healthtech funding
After a period of caution, large rounds are returning to companies with clear paths to revenue and real-world operations. The pattern favors businesses that deliver care, not only software that supports it. Investors appear to have learned that technology alone does not fix healthcare; it needs doctors, buildings and trust.
A day in the life of a hybrid clinic
Picture a patient with a persistent cough. She opens the app at breakfast, answers a few questions and is offered a slot at lunchtime in a clinic ten minutes from her office. The doctor already has her history on screen, listens to her chest, orders a quick test and sends the results to the app by the afternoon. A follow-up message the next day checks how she is feeling. At no point did she fill in a paper form or repeat her story. That smoothness is the main selling point, and it is also what the company must deliver consistently, at every site, to justify its expansion.
Who pays and why that matters
Because reimbursement rules differ between countries, the same visit can be profitable in one market and lossmaking in another. Investors will want to see how quickly new clinics reach break-even and whether the digital tools truly raise the number of patients each clinician can see without hurting quality.
The takeaway
The hybrid approach is neither a gimmick nor a guaranteed success. It tackles real frustrations: long waits, paperwork and fragmented records. If a company can deliver good care while keeping costs under control, it can grow. Watch how it performs in its second and third countries, because that is where the model will be properly tested.
